Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2019 Oct 30;29(1):31–38. doi: 10.1158/1055-9965.EPI-19-0538

Table 2.

Baseline characteristics of study patients according to p16 status.

p16 positive (n = 90) p16 negative (n = 131) P

Age, y 0.0048
 0–59 56 (62%) 55 (42%)
 60+ 34 (38%) 76 (58%)
Sex 0.1403
 Male 72 (80%) 92 (70%)
 Female 18 (20%) 39 (30%)
TNM7 <0.0001
 I 1 (1%) 18 (14%)
 II 6 (7%) 22 (17%)
 III 14 (16%) 21 (16%)
 IV 69 (77%) 61 (47%)
 Missing 0 (0%) 9 (7%)
Smoker status <0.0001
 Never or previous 47 (52%) 29 (22%)
 Current 22 (24%) 69 (53%)
 Missing 21 (23%) 33 (25%)
Alcohol history 0.8181
 No 13 (14%) 21 (16%)
 Yes 41 (46%) 63 (48%)
 Missing 36 (40%) 47 (36%)
Curative intent with surgery 0.0024
 Yes 60 (67%) 64 (49%)
 No 25 (28%) 39 (30%)
 No treatment/palliative 5 (6%) 28 (21%)

Note: Data are presented as number of patients (%). Differences in patient characteristics according to p16 status were compared using Fisher exact test for categorical variables.